Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial). [electronic resource]
Producer: 20200629Description: 735-743 p. digitalISSN:- 1879-1913
- Age Factors
- Aged
- Aged, 80 and over
- Anticoagulants -- therapeutic use
- Aspirin -- therapeutic use
- Atrial Fibrillation -- complications
- Clopidogrel -- therapeutic use
- Coronary Artery Disease -- therapy
- Dabigatran -- therapeutic use
- Drug Therapy, Combination
- Female
- Hemorrhage -- chemically induced
- Humans
- Male
- Middle Aged
- Myocardial Revascularization -- statistics & numerical data
- Percutaneous Coronary Intervention
- Platelet Aggregation Inhibitors -- therapeutic use
- Proportional Hazards Models
- Stroke -- etiology
- Thromboembolism -- epidemiology
- Ticagrelor -- therapeutic use
- Treatment Outcome
- Warfarin -- therapeutic use
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.